We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+37.69%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$7.48B
AUM Growth
+$1.44B
Cap. Flow
-$77.6M
Cap. Flow %
-1.04%
Top 10 Hldgs %
23.83%
Holding
336
New
58
Increased
161
Reduced
69
Closed
35

Top Buys

Rank Stock Value
1
AVLN
Avalyn Pharma
AVLN
+$39.7M
2
CDNS icon
Cadence Design Systems
CDNS
+$29.6M
3
RELY icon
Remitly
RELY
+$27.3M
4
DELL icon
Dell
DELL
+$25.5M
5
FITB
Fifth Third Bancorp
FITB
+$25.3M

Top Sells

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$57.8M
2
PLD icon
Prologis
PLD
+$56.1M
3
GH icon
Guardant Health
GH
+$44M
4
AXSM icon
Axsome Therapeutics
AXSM
+$44M
5
GLBE icon
Global E Online
GLBE
+$37.6M

Sector Composition

Rank Sector Weight
1 Healthcare 36.37%
2 Technology 22.57%
3 Industrials 20.48%
4 Energy 5.51%
5 Utilities 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
26
Royalty Pharma
RPRX
$27.1B
$77.7M 1.04%
1,380,261
+67,727
+5% +$3.53M
AXSM icon
27
Axsome Therapeutics
AXSM
$10.4B
$77.5M 1.04%
316,820
-202,738
-39% -$44M
TER icon
28
Teradyne
TER
$55.5B
$71.4M 0.95%
147,984
+20,518
+16% +$7.74M
DHI icon
29
D.R. Horton
DHI
$41.2B
$71.1M 0.95%
436,562
+5,691
+1% +$849K
TOST icon
30
Toast
TOST
$20.3B
$69.4M 0.93%
2,494,706
+6,037
+0.2% +$157K
PWR icon
31
Quanta Services
PWR
$90.6B
$67.1M 0.9%
93,231
+3,845
+4% +$2.63M
WMB icon
32
Williams Companies
WMB
$90.2B
$66.9M 0.89%
898,241
+65,993
+8% +$4.86M
MTD icon
33
Mettler-Toledo International
MTD
$28B
$66.5M 0.89%
52,116
+1,365
+3% +$1.65M
INSM icon
34
Insmed
INSM
$25.9B
$62.2M 0.83%
583,665
+37,355
+7% +$4.52M
RBA icon
35
RB Global
RBA
$15.9B
$61.5M 0.82%
528,645
+502
+0.1% +$52.8K
LBRT icon
36
Liberty Energy
LBRT
$3.1B
$60.6M 0.81%
2,314,729
-88,369
-4% -$2.64M
BLTE
37
Belite Bio
BLTE
$6.11B
$60.2M 0.8%
390,829
+33,179
+9% +$5.09M
DTM icon
38
DT Midstream
DTM
$13.2B
$59.8M 0.8%
407,626
+5,675
+1% +$803K
KYMR icon
39
Kymera Therapeutics
KYMR
$9.82B
$57.8M 0.77%
504,210
-122,715
-20% -$10.5M
NDAQ icon
40
Nasdaq
NDAQ
$55.5B
$55.9M 0.75%
711,213
-626
-0.1% -$54.9K
SITM icon
41
SiTime
SITM
$16.8B
$55.1M 0.74%
74,014
+349
+0.5% +$220K
NI icon
42
NiSource
NI
$19.5B
$55.1M 0.74%
1,158,290
+14,700
+1% +$696K
ESI icon
43
Element Solutions
ESI
$8.51B
$54.7M 0.73%
1,149,055
-22,412
-2% -$930K
NVDA icon
44
NVIDIA
NVDA
$5.25T
$54.4M 0.73%
273,735
+14,316
+6% +$2.94M
ABVX
45
Abivax
ABVX
$9.89B
$52.6M 0.7%
394,957
+74,381
+23% +$8.42M
VMC icon
46
Vulcan Materials
VMC
$35.6B
$50.1M 0.67%
169,825
+253
+0.1% +$72.5K
ORLY icon
47
O'Reilly Automotive
ORLY
$71.6B
$50M 0.67%
544,082
+4,202
+0.8% +$383K
TRVI icon
48
Trevi Therapeutics
TRVI
$2.39B
$49.6M 0.66%
2,660,000
+37,694
+1% +$548K
COLL icon
49
Collegium Pharmaceutical
COLL
$786M
$49.3M 0.66%
1,361,228
-63,054
-4% -$2.15M
EGP icon
50
EastGroup Properties
EGP
$10.8B
$48.9M 0.65%
241,049
+5,319
+2% +$1.07M
1
2
3 4 5

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Eventide Asset Management held 336 positions worth $7.48B, up 24% from $6.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q2 2026 filing shows 58 new, 161 increased, 69 reduced and 35 closed positions. Its largest new stake was Avalyn Pharma: 1,375,486 shares worth $45.3M. The largest sale was Xometry, an estimated $57.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2026 buy was Avalyn Pharma: 1,375,486 shares worth $45.3M.
  • Eventide Asset Management added most to Cadence Design Systems in Q2 2026, an estimated $29.6M increase.
  • Eventide Asset Management's biggest Q2 2026 reduction was Xometry, cutting an estimated $57.8M.
  • Eventide Asset Management fully exited Prologis in Q2 2026, selling an estimated $56.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $7.48B portfolio in Q2 2026.
  • Eventide Asset Management opened 58 new positions and closed 35 in Q2 2026.
  • Eventide Asset Management's portfolio value rose 24% quarter-over-quarter to $7.48B.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.